Group One Trading’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,131
Closed -$146K 5826
2019
Q2
$124K Buy
+2,131
New +$126K ﹤0.01% 3179
2018
Q4
Sell
-400
Closed -$28K 5752
2018
Q3
$28K Buy
+400
New +$23.4K ﹤0.01% 4277
2018
Q2
Sell
-420
Closed -$16.7K 5706
2018
Q1
$13K Buy
420
+20
+5% +$664 ﹤0.01% 4248
2017
Q4
$14K Buy
+400
New +$12.8K ﹤0.01% 4295
2015
Q3
Sell
-965
Closed -$24.9K 5404
2015
Q2
$27K Sell
965
-11,626
-92% -$328K ﹤0.01% 3903
2015
Q1
$385K Buy
12,591
+10,495
+501% +$334K 0.01% 1830
2014
Q4
$67K Buy
+2,096
New +$68.2K ﹤0.01% 3161
2014
Q3
Sell
-530
Closed -$14.8K 5621
2014
Q2
$15K Sell
530
-2,748
-84% -$73.1K ﹤0.01% 4342
2014
Q1
$86K Buy
+3,278
New +$94.1K ﹤0.01% 3205
2013
Q4
Sell
-178
Closed -$5.65K 5689
2013
Q3
$5K Sell
178
-6,200
-97% -$207K ﹤0.01% 4774
2013
Q2
$202K Buy
+6,378
New +$209K 0.01% 2164

Group One Trading's GHDX Position: Q3 2019 in Review

Group One Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 2,131 shares — an estimated $146K sold.

Group One Trading first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $385K in Q1 2015. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Group One Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 2,131 Genomic Health, Inc. shares in Q3 2019, an estimated $146K.
  • Group One Trading first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Genomic Health, Inc. position peaked at $385K in Q1 2015.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.